Skip to content
SSBMT Logo
  • HOME
  • ABOUT US
    • What Is SSBMT
    • The SSBMT Board
    • Membership
    • SSBMT Sponsorship
  • REGISTRIES
    • Saudi Blood and Marrow Transplantation Registry
    • Disease Registry for Myeloproliferative Neoplasm
    • Lymphoproliferative Disorder
    • Chronic Myelogenous Leukemia Registry
  • ACTIVITIES
    • Announcements
    • Newsletters
      • August 2020
      • December 2020
    • Events Calendar
    • Upcoming Events
    • Previous Events
  • SHRG
    • What is SHRG
    • SSBMT Hematology Research Award
  • More
    • PATIENT RESOURCES
  • العربية
Loading...
Newsletter Decalkowiterar2021-06-21T09:25:47+03:00
alkowiterar2021-05-26T12:12:02+03:00
WHY SHOULD I GET VACCINATED?

WHY SHOULD I GET VACCINATED?

WHY SHOULD I GET VACCINATED?

According to the World Health Organization (WHO), we are at risk of severe illness and disability..

alkowiterar2021-05-26T12:29:32+03:00
PREVALENCE OF GLUCOSE-6- PHOSPHATE DEHYDROGENASE DEFICIENCY AMONG CHILDREN IN EASTERN SAUDI ARABIA

PREVALENCE OF GLUCOSE-6- PHOSPHATE DEHYDROGENASE DEFICIENCY AMONG CHILDREN IN EASTERN SAUDI ARABIA

PREVALENCE OF GLUCOSE-6- PHOSPHATE DEHYDROGENASE DEFICIENCY AMONG CHILDREN IN EASTERN SAUDI ARABIA

25,628 Saudi newborns were screened for G6PD

alkowiterar2021-05-26T12:30:51+03:00
COVID-19 VACCINE: GLOBAL CHALLENGES & PROSPECTS FORUM

COVID-19 VACCINE: GLOBAL CHALLENGES & PROSPECTS FORUM

COVID-19 VACCINE: GLOBAL CHALLENGES & PROSPECTS FORUM

The 11th Annual Forum for Medical Research with the theme “COVID-19 Vaccine

alkowiterar2021-05-26T12:32:41+03:00
HIGH RATE OF BLEEDING AND ARTERIAL THROMBOSIS IN COVID-19: SAUDI MULTICENTER STUDY

HIGH RATE OF BLEEDING AND ARTERIAL THROMBOSIS IN COVID-19: SAUDI MULTICENTER STUDY

HIGH RATE OF BLEEDING AND ARTERIAL THROMBOSIS IN COVID-19: SAUDI MULTICENTER STUDY

A Saudi multicenter retrospective study to assess the rate of arterial and venous thrombosis in COVID-19 patients..

alkowiterar2021-05-26T12:37:59+03:00
SSBMT WEBINAR SERIES

SSBMT WEBINAR SERIES

SSBMT WEBINAR SERIES

speakers who shared their expertise in their field of specialty

alkowiterar2021-05-26T12:50:44+03:00
SAFETY AND EFFICACY OF CONVALESCENT PLASMA FOR SEVERE COVID-19: INTERIM REPORT OF A MULTICENTER PHASE II STUDY FROM SAUDI ARABIA

SAFETY AND EFFICACY OF CONVALESCENT PLASMA FOR SEVERE COVID-19: INTERIM REPORT OF A MULTICENTER PHASE II STUDY FROM SAUDI ARABIA

SAFETY AND EFFICACY OF CONVALESCENT PLASMA FOR SEVERE COVID-19: INTERIM REPORT OF A MULTICENTER PHASE II STUDY FROM SAUDI ARABIA

Al Shehry et al reported the interim findings of the Phase II trial..

alkowiterar2021-05-26T12:59:33+03:00
WHAT IS CAR T-CELL THERAPY AND HOW DOES IT WORK?

WHAT IS CAR T-CELL THERAPY AND HOW DOES IT WORK?

WHAT IS CAR T-CELL THERAPY AND HOW DOES IT WORK?

Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment.

alkowiterar2021-05-26T13:00:22+03:00
HEMATOPOIETIC STEM CELL TRANSPLANT PROGRAM AT MNGHA; 1000 TRANSPLANTS – 10 YEARS OF PASSION AND SUCCESS

HEMATOPOIETIC STEM CELL TRANSPLANT PROGRAM AT MNGHA; 1000 TRANSPLANTS – 10 YEARS OF PASSION AND SUCCESS

HEMATOPOIETIC STEM CELL TRANSPLANT PROGRAM AT MNGHA; 1000 TRANSPLANTS – 10 YEARS OF PASSION AND SUCCESS

The Stem Cell Transplant Program in Health Affairs of the National Guard in Riyadh has completed ten years since its opening in 2010

alkowiterar2021-05-26T13:01:34+03:00
AMOTOSALEN AND ULTRAVIOLET A LIGHT TREATMENT EFFICIENTLY INACTIVATES SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN HUMAN PLASMA

AMOTOSALEN AND ULTRAVIOLET A LIGHT TREATMENT EFFICIENTLY INACTIVATES SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN HUMAN PLASMA

AMOTOSALEN AND ULTRAVIOLET A LIGHT TREATMENT EFFICIENTLY INACTIVATES SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) IN HUMAN PLASMA

In a study published in VoxSanguinis , Esam Azhar et. al. confirmed the complete effectiveness of amotosalen

alkowiterar2023-03-22T11:38:18+03:00
THE ERA OF VIRTUAL CONFERENCES

THE ERA OF VIRTUAL CONFERENCES

THE ERA OF VIRTUAL CONFERENCES

COVID-19 has provided an opportunity to redefine the scientific conference. Online meetings have become the norm, so how can we make the most of them? The online meetings might lack many of the onsite conference benefits such as conversations over breaks and dinners, face-to-face networking, fresh outlooks, etc.

Overview

  • About us
  • Membership
  • SSBMT Hematology Reserch Award
  • Privacy Policy

Contact & Support

  • Contact Us
  • Announcements
  • Partners
  • Terms of Use

Social Media

Site Map

©2020 SSBMT - ACT, All Rights Reserved.

saudi hematology
Page load link
Go to Top